- Home
- VOR vs TRNS Comparison
VOR vs TRNS Comparison
Compare VOR & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | TRNS |
|---|---|---|
| Founded | 2015 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 542.9M |
| IPO Year | 2021 | 1995 |
Fundamental Metrics
Financial Performance| Metric | VOR | TRNS |
|---|---|---|
| Price | $15.02 | $70.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $64.78 | ★ $116.00 |
| AVG Volume (30 Days) | ★ 618.2K | 144.1K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.86 | N/A |
| EPS | N/A | ★ 0.37 |
| Revenue | N/A | ★ $278,421,000.00 |
| Revenue This Year | N/A | $21.75 |
| Revenue Next Year | N/A | $7.55 |
| P/E Ratio | ★ N/A | $191.53 |
| Revenue Growth | N/A | ★ 7.30 |
| 52 Week Low | $0.13 | $50.23 |
| 52 Week High | $49.95 | $97.08 |
Technical Indicators
Market Signals| Indicator | VOR | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 54.03 | 43.27 |
| Support Level | $11.76 | $56.95 |
| Resistance Level | $16.95 | $81.17 |
| Average True Range (ATR) | 1.13 | 3.14 |
| MACD | 0.03 | -1.34 |
| Stochastic Oscillator | 51.75 | 22.39 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.